Internal Medicine, Pulmonary Disease · Aurora, CO
NPI
1275623951
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
12605 E 16th Ave
Aurora, CO, 80045
Phone (720) 848-0000
Groups this clinician bills Medicare through
Medicare paid, 2024
$33K
397 services
Medicare patients, 2024
170
Average age 70
Drug cost, 2024
$6.1M
1,106 prescriptions
Company payments, 2025
$42K
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David Badesch was code 99214 (office e&m - established), 109 times for 80 patients. In total David Badesch billed 397 services in 17 codes, and Medicare paid $33K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-10-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 109 | 80 | $69.98 | $7,628 |
| 99215 Office E&M - Established | Facility | 104 | 72 | $108.24 | $11K |
| 99233 Hospital E&M - Subsequent | Facility | 52 | 19 | $92.06 | $4,787 |
| 99213 Office E&M - Established | Facility | 39 | 34 | $50.71 | $1,978 |
| 99232 Hospital E&M - Subsequent | Facility | 39 | 25 | $60.62 | $2,364 |
| 99222 Hospital E&M - Initial | Facility | 11 | 11 | $99.91 | $1,099 |
By year: 2022 $45K for 586 services; 2023 $35K for 425 services; 2024 $33K for 397 services.
Medicare prescription drug claims, 2024
In 2024, the drug David Badesch prescribed most often to Medicare patients was Ambrisentan, with 162 prescriptions and refills. In total David Badesch wrote 1,106 Medicare prescriptions that cost $6.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ambrisentan Generic | 162 | 172 | 18 | $436K |
| Opsumit Macitentan | 134 | 134 | 13 | $1.6M |
| Tadalafil Generic | 123 | 179 | 17 | $80K |
| Uptravi Selexipag | 89 | 89 | Under 11 | $2.1M |
| Sildenafil Citrate Generic | 85 | 224 | 22 | $44K |
| Furosemide Generic | 83 | 241 | 32 | $576 |
| Spironolactone Generic | 76 | 195 | 20 | $893 |
| Potassium Chloride Generic | 60 | 131 | 17 | $1,896 |
| Amlodipine Besylate Generic | 45 | 124 | 11 | $153 |
| Xarelto Rivaroxaban | 35 | 39 | Under 11 | $20K |
| Tyvaso Dpi Treprostinil | 32 | 32 | Under 11 | $761K |
| Bumetanide Generic | 31 | 67 | Under 11 | $4,914 |
| Bosentan Generic | 25 | 25 | Under 11 | $187K |
| Adempas Riociguat | 23 | 23 | Under 11 | $320K |
| Orenitram Er Treprostinil Diolamine | 22 | 22 | Under 11 | $193K |
Brand drugs: 382 claims; generic drugs: 724 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David Badesch $42K ($42K in general payments such as food, travel and fees) from 4 companies. The largest payer was Merck Sharp & Dohme LLC with $42K.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 48 | $42K |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.